Ovid Therapeutics: Bullish Post-PIPE With 2 Differentiated CNS Moonshots

Company Overview - Ovid Therapeutics Inc. (OVID) is a CNS drug developer focusing on therapies for disorders related to neuronal hyperexcitability [1] Pipeline Focus - OVID's pipeline primarily targets two mechanisms: 1) A GABA-AT inhibitor aimed at treating uncontrolled epilepsy 2) KCC2 [1]